Among these pathways, we identified NSCLC pathway, SCLC pathway, Pathways in cancer, Proteoglycans in cancer, Choline metabolism in cancer, Central carbon metabolism in cancer, p53 signaling, MAPK, mTOR signaling, PI3K‐Akt, etc. A complete list of the enriched pathways and their significance is in the supplementary material (Fig. S5 and Table S2). The gene discussed is TP53; the disease is non-small cell lung carcinoma.